Search research articles
Contact Us
Filters
Showing results (61-70 of 119) with videos related to
Page
of 12
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma
Yolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Blood Cancer Discovery
|
May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy
George Mo, Sang Y Lee, David G Coffey, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotype
Sang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions
Sang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
July 30, 2022
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
Mengchao An, Wenkang Wang, Jie Zhang, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma
Carrie Ho, Neena Kennedy, Mengyang Di, et al.
British Journal of Haematology
|
October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601
Brian G Till, Hongli Li, Steven H Bernstein, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell Lymphoma
Stephen E Spurgeon, Brian G Till, Peter Martin, et al.
JCO Oncology Practice
|
November 18, 2024
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience
Ivan J Huang, Grace T Baek, Jonathan Cohen, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 119) with videos related to
Sort By:
Page
of 12
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 25, 2017
Total Body Irradiation Is Safe and Similarly Effective as Chemotherapy-Only Conditioning in Autologous Stem Cell Transplantation for Mantle Cell Lymphoma
Yolanda D Tseng, Philip A Stevenson, Ryan D Cassaday, et al.
Blood Cancer Discovery
|
May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell Therapy
George Mo, Sang Y Lee, David G Coffey, et al.
Journal for Immunotherapy of Cancer
|
January 22, 2024
CD8<sup>+</sup> chimeric antigen receptor T cells manufactured in absence of CD4<sup>+</sup> cells exhibit hypofunctional phenotype
Sang Yun Lee, Dong Hoon Lee, Wei Sun, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
November 28, 2017
Preclinical Optimization of a CD20-specific Chimeric Antigen Receptor Vector and Culture Conditions
Sang Yun Lee, Philip Olsen, Dong Hoon Lee, et al.
Cancer Immunology, Immunotherapy : CII
|
July 30, 2022
Association of hepatitis B virus DNA levels with overall survival for advanced hepatitis B virus-related hepatocellular carcinoma under immune checkpoint inhibitor therapy
Mengchao An, Wenkang Wang, Jie Zhang, et al.
Bone Marrow Transplantation
|
May 24, 2016
Bendamustine, etoposide and dexamethasone to mobilize peripheral blood hematopoietic stem cells for autologous transplantation in patients with multiple myeloma
D J Green, W I Bensinger, L A Holmberg, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 24, 2025
Barriers to Investigator-Initiated Clinical Trial Enrollment in Frontline Large B-Cell Lymphoma
Carrie Ho, Neena Kennedy, Mengyang Di, et al.
British Journal of Haematology
|
October 23, 2015
Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601
Brian G Till, Hongli Li, Steven H Bernstein, et al.
Journal of the National Cancer Institute
|
January 2, 2017
Recommendations for Clinical Trial Development in Mantle Cell Lymphoma
Stephen E Spurgeon, Brian G Till, Peter Martin, et al.
JCO Oncology Practice
|
November 18, 2024
Clinical Relevance of Intensive Laboratory Monitoring With Standard Venetoclax Ramp-Up for Chronic Lymphocytic Leukemia: A Real-World Experience
Ivan J Huang, Grace T Baek, Jonathan Cohen, et al.
Page
of 12